[Beta blockers in heart failure. Experiences and recommendations for clinical use. ANMCO-Area Heart Failure]

G Ital Cardiol. 1998 Jan;28(1):61-70.
[Article in Italian]
No abstract available

Publication types

  • Comparative Study
  • Review

MeSH terms

  • Adrenergic beta-Antagonists / administration & dosage
  • Adrenergic beta-Antagonists / therapeutic use*
  • Aged
  • Bisoprolol / administration & dosage
  • Bisoprolol / therapeutic use
  • Carbazoles / administration & dosage
  • Carbazoles / therapeutic use
  • Carvedilol
  • Controlled Clinical Trials as Topic
  • Follow-Up Studies
  • Heart Failure / drug therapy*
  • Heart Failure / mortality
  • Heart Failure / physiopathology
  • Humans
  • Metoprolol / administration & dosage
  • Metoprolol / therapeutic use
  • Propanolamines / administration & dosage
  • Propanolamines / therapeutic use
  • Prospective Studies
  • Randomized Controlled Trials as Topic
  • Time Factors
  • Vasodilator Agents / administration & dosage
  • Vasodilator Agents / therapeutic use

Substances

  • Adrenergic beta-Antagonists
  • Carbazoles
  • Propanolamines
  • Vasodilator Agents
  • Carvedilol
  • Metoprolol
  • Bisoprolol